Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Tuesday, November 8th. Shareholders of record on Friday, December 2nd will be given a dividend of 0.13 per share on Tuesday, January 3rd. This represents a $0.52 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Wednesday, November 30th.

Baxter International (NYSE:BAX) opened at 46.61 on Tuesday. The firm has a 50-day moving average of $47.22 and a 200-day moving average of $46.46. The stock has a market capitalization of $25.35 billion, a price-to-earnings ratio of 5.22 and a beta of 0.88. Baxter International has a 1-year low of $34.06 and a 1-year high of $50.16.

Baxter International (NYSE:BAX) last announced its earnings results on Tuesday, October 25th. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.11. Baxter International had a net margin of 48.68% and a return on equity of 11.43%. The business earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.67 billion. During the same period in the prior year, the company earned $0.41 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. Equities research analysts anticipate that Baxter International will post $1.91 EPS for the current year.

Dividend History for Baxter International (NYSE:BAX)

TRADEMARK VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2016/11/29/baxter-international-inc-bax-to-go-ex-dividend-on-november-30th.html.

A number of equities research analysts have recently commented on the stock. Zacks Investment Research cut shares of Baxter International from a “buy” rating to a “hold” rating in a report on Thursday, October 6th. Barclays PLC assumed coverage on shares of Baxter International in a report on Thursday, September 15th. They issued an “overweight” rating and a $52.00 target price for the company. Wells Fargo & Co. assumed coverage on shares of Baxter International in a report on Thursday, October 13th. They issued an “outperform” rating for the company. Evercore ISI reaffirmed a “buy” rating and issued a $56.00 target price (up from $52.00) on shares of Baxter International in a report on Wednesday, October 26th. Finally, RBC Capital Markets reaffirmed a “sector perform” rating and issued a $55.00 target price (up from $50.00) on shares of Baxter International in a report on Wednesday, October 26th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $51.30.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Stonebridge Capital Advisors LLC bought a new position in shares of Baxter International during the second quarter valued at $215,000. SevenBridge Financial Group LLC acquired a new stake in Baxter International during the second quarter valued at approximately $216,000. LPL Financial LLC raised its stake in Baxter International by 8.1% in the third quarter. LPL Financial LLC now owns 15,032 shares of the company’s stock valued at $711,000 after buying an additional 1,124 shares in the last quarter. Johnson Investment Counsel Inc. raised its stake in Baxter International by 34.9% in the second quarter. Johnson Investment Counsel Inc. now owns 15,103 shares of the company’s stock valued at $682,000 after buying an additional 3,908 shares in the last quarter. Finally, Thrivent Financial for Lutherans raised its stake in Baxter International by 5.9% in the second quarter. Thrivent Financial for Lutherans now owns 17,281 shares of the company’s stock valued at $782,000 after buying an additional 970 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

About Baxter International

Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.

5 Day Chart for NYSE:BAX

Receive News & Stock Ratings for Baxter International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International Inc. and related stocks with our FREE daily email newsletter.